Macular neovascularization lesion type and vision outcomes in neovascular age-related macular degeneration: post hoc analysis of HARBOR

被引:0
|
作者
K. Bailey Freund
Giovanni Staurenghi
Jesse J. Jung
Sandrine A. Zweifel
Mariano Cozzi
Lauren Hill
Steven Blotner
Min Tsuboi
Shamika Gune
机构
[1] Vitreous Retina Macula Consultants of New York,Department of Ophthalmology
[2] NYU Grossman School of Medicine,Department of Biomedical and Clinical Science Luigi Sacco
[3] Luigi Sacco Hospital,Department of Ophthalmology
[4] University of Milan,Department of Ophthalmology
[5] East Bay Retina Consultants,undefined
[6] Inc.,undefined
[7] University of California,undefined
[8] University Hospital Zurich,undefined
[9] University of Zurich,undefined
[10] Genentech,undefined
[11] Inc.,undefined
来源
Graefe's Archive for Clinical and Experimental Ophthalmology | 2022年 / 260卷
关键词
Consensus on Neovascular Age-Related Macular Degeneration Nomenclature (CONAN); Macular neovascularization; Neovascular age-related macular degeneration; Ranibizumab; Visual acuity;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2437 / 2447
页数:10
相关论文
共 50 条
  • [21] Vision protection therapy for prevention of neovascular age-related macular degeneration
    Jeffrey K. Luttrull
    Gerry Gray
    Sathy V. Bhavan
    Scientific Reports, 13 (1)
  • [22] Rate of vision loss in neovascular age-related macular degeneration explored
    Juan P. Real
    Gladys E. Granero
    Mariana O. De Santis
    Claudio P. Juarez
    Santiago D. Palma
    Simon P. Kelly
    José D. Luna
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2015, 253 : 1859 - 1865
  • [23] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [24] Pegaptanib for neovascular age-related macular degeneration
    Gragoudas, ES
    Adamis, AP
    Cunningham, ET
    Feinsod, M
    Guyer, DR
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (27): : 2805 - 2816
  • [25] Management of neovascular age-related macular degeneration
    Schmidt-Erfurth, Ursula M.
    Pruente, Christian
    PROGRESS IN RETINAL AND EYE RESEARCH, 2007, 26 (04) : 437 - 451
  • [26] Imaging in Neovascular Age-Related Macular Degeneration
    Gess, Adam J.
    Fung, Anne E.
    Rodriguez, Jorge G.
    SEMINARS IN OPHTHALMOLOGY, 2011, 26 (03) : 225 - 233
  • [27] Radiotherapy for neovascular age-related macular degeneration
    Evans, Jennifer R.
    Sivagnanavel, Vasuki
    Chong, Victor
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [28] Aflibercept for neovascular age-related macular degeneration
    Sarwar, Salman
    Clearfield, Elizabeth
    Soliman, Mohamed Kamel
    Sadiq, Mohammad Ali
    Baldwin, Andrew J.
    Hanout, Mostafa
    Agarwal, Aniruddha
    Sepah, Yasir J.
    Do, Diana V.
    Quan Dong Nguyen
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (02):
  • [29] Bevacizumab for Neovascular Age-Related Macular Degeneration
    Silva, Aline
    Furlan, Luiz
    Elias, Flavia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 75 - 76
  • [30] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749